Your browser doesn't support javascript.
loading
miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2.
Zhao, Wen-Tao; Lin, Xiao-Lin; Liu, Yu; Han, Liu-Xin; Li, Jing; Lin, Tao-Yan; Shi, Jun-Wen; Wang, Sheng-Chun; Lian, Mei; Chen, Heng-Wei; Sun, Yan; Xu, Kang; Jia, Jun-Shuang; Luo, Rong-Cheng; Xiao, Dong.
Afiliación
  • Zhao WT; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, 510515, China.
  • Lin XL; Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, 510315, China.
  • Liu Y; Department of Medical Oncology, The Third Affiliated Hospital of Kunming Medical University (Tumour Hospital of Yunnan Province), Kunming, 650118, China.
  • Han LX; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, 510515, China.
  • Li J; Institute of Comparative Medicine & Laboratory Animal Center, Southern Medical University, Guangzhou, 510515, China.
  • Lin TY; The Third People's Hospital of Kunming, Kunming, 650041, China.
  • Shi JW; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, 510515, China.
  • Wang SC; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, 510515, China.
  • Lian M; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, 510515, China.
  • Chen HW; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Science, Southern Medical University, Guangzhou, 510515, China.
  • Sun Y; Institute of Comparative Medicine & Laboratory Animal Center, Southern Medical University, Guangzhou, 510515, China.
  • Xu K; Institute of Comparative Medicine & Laboratory Animal Center, Southern Medical University, Guangzhou, 510515, China.
  • Jia JS; Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
  • Luo RC; Department of General Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Xiao D; Guangdong Provincial Key Laboratory of Malignant Tumour Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Lab Invest ; 99(10): 1484-1500, 2019 10.
Article en En | MEDLINE | ID: mdl-31201367

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / MicroARNs / Fosfohidrolasa PTEN / Proteína Potenciadora del Homólogo Zeste 2 / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Lab Invest Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / MicroARNs / Fosfohidrolasa PTEN / Proteína Potenciadora del Homólogo Zeste 2 / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Lab Invest Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos